Cite
Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma.
MLA
Liao, Rachel G., et al. “Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma.” Cancer Research, vol. 73, no. 16, Aug. 2013, pp. 5195–205. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-12-3950.
APA
Liao, R. G., Jung, J., Tchaicha, J., Wilkerson, M. D., Sivachenko, A., Beauchamp, E. M., Liu, Q., Pugh, T. J., Pedamallu, C. S., Hayes, D. N., Gray, N. S., Getz, G., Wong, K.-K., Haddad, R. I., Meyerson, M., & Hammerman, P. S. (2013). Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma. Cancer Research, 73(16), 5195–5205. https://doi.org/10.1158/0008-5472.CAN-12-3950
Chicago
Liao, Rachel G, Joonil Jung, Jeremy Tchaicha, Matthew D Wilkerson, Andrey Sivachenko, Ellen M Beauchamp, Qingsong Liu, et al. 2013. “Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma.” Cancer Research 73 (16): 5195–5205. doi:10.1158/0008-5472.CAN-12-3950.